Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Chondrial Therapeutics raises $22.6mm in Series A round

Executive Summary

Chondrial Therapeutics Inc. (orphan drugs for mitochondrial diseases) raised $22.6mm in a Series A financing round led by Deerfield Management. Chondrial appointed former Deerfield advisor Carole Ben-Maimon, MD, as its CEO. A minority investment by the Catalyst Fund--a $15mm Wake Forest Innovation technology development fund managed by Pappas Capital--was also part of the round.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
    • Drug Discovery Tools
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies